B
Bhawarlal
About Bhawarlal
Data last updated:
Bhawarlal is a Director at Drl Generics-1 Private Limited (since 2023), Director at Idrs Labs Private Limited (since 2024) and Director at Mahaveer Medichem Private Limited (since 2024). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹94.03 Cr; the largest is Drl Generics-1 Private Limited at ₹80.30 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Drl Generics-1 Private Limited U46497KA2023PTC174573 | Director | 05 Jun 2023 | 2023 | ₹80.30 Cr (FY 2025) | Active |
 Idrs Labs Private Limited U74900KA2012PTC080472 | Director | 24 Oct 2024 | 2012 | ₹13.72 Cr (FY 2025) | Active |
| Mahaveer Medichem Private Limited U46497KA2023PTC177142 | Director | 05 Aug 2024 | 2023 | Active |
Board colleagues of Bhawarlal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Yogesh Bhandari | 00571830 | Drl Generics-1 Private Limited , Idrs Labs Private Limited | Director |
| Kavitha Paramesh | 03302040 | Idrs Labs Private Limited | Additional Director |
| Mahendra Joshi | 06517586 | Idrs Labs Private Limited | Director |
| Shivkumar Vijaykumar Madki | 06517609 | Idrs Labs Private Limited | Director |
| Daksh Bhandari | 10267327 | Mahaveer Medichem Private Limited | Director |
| Varsha Bhandari | 10273347 | Mahaveer Medichem Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Bhawarlal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bhawarlal
Bhawarlal currently holds 3 directorships: Drl Generics-1 Private Limited (Director, since 05 Jun 2023, revenue ₹80.30 Cr (FY 2025)); Idrs Labs Private Limited (Director, since 24 Oct 2024, revenue ₹13.72 Cr (FY 2025)); Mahaveer Medichem Private Limited (Director, since 05 Aug 2024).
Bhawarlal was first appointed on 05 Jun 2023 as Director at Drl Generics-1 Private Limited. The most recent appointment on record is 24 Oct 2024 at Idrs Labs Private Limited.
The 2 current companies of Bhawarlal that report revenue have a combined latest revenue of ₹94.03 Cr: Drl Generics-1 Private Limited ₹80.30 Cr (FY 2025); Idrs Labs Private Limited ₹13.72 Cr (FY 2025).
The current boards of Bhawarlal's companies include Yogesh Bhandari (Drl Generics-1 Private Limited), Kavitha Paramesh (Idrs Labs Private Limited), Mahendra Joshi (Idrs Labs Private Limited), Shivkumar Vijaykumar Madki (Idrs Labs Private Limited), Daksh Bhandari (Mahaveer Medichem Private Limited), Varsha Bhandari (Mahaveer Medichem Private Limited).